Clobazam Suspension
Product Images NDC 69238-1535

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 69238-1535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Clobazam Oral Suspension 1)

Chemical structure of clobazam, illustrating the molecular arrangement including a chlorinated benzene ring and a diazepine fused ring system with ketone groups.*

FDA Label Image

Figure G (Clobazam Oral Suspension 10)

A close-up image showing a dosing syringe measuring oral medication. The syringe is marked with volume graduations from 1 mL to 10 mL and includes a note to measure to the edge of the plunger. Text on the syringe reads 'For Oral Administration Only.' The syringe is partially filled, connected to a brown bottle, illustrating how to measure liquid oral suspension medication accurately.*

FDA Label Image

Figure H (Clobazam Oral Suspension 11)

An illustration showing an oral syringe being used to administer liquid medication orally to a young child. The syringe is marked with measurement lines and labeled 'For Oral Administration Only.' This demonstrates proper oral dosing technique for liquid suspension medications.*

FDA Label Image

Figure I (Clobazam Oral Suspension 12)

Clobazam Oral Suspension 2.5 mg/mL in an amber glass bottle with a white child-resistant cap. The label shows the product name, strength, and partial NDC number 69238-1535. The bottle is being opened by a hand, demonstrating cap removal. The labeler is Amneal Pharmaceuticals NY LLC.*

FDA Label Image

Label (Clobazam Oral Suspension 13)

Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottle label by Amneal Pharmaceuticals LLC. The label includes dosage strength per mL, storage instructions to keep between 20° to 25°C, and directions to shake well before use. It states use is for oral administration only and to discard 90 days after opening. The label also shows the NDC 69238-1535-2 and a bar code.*

FDA Label Image

1 (Clobazam Oral Suspension 14)

Folded carton label for Clobazam Oral Suspension 2.5 mg/mL, a human prescription oral suspension by Amneal Pharmaceuticals NY LLC. The label includes the product name, strength, dosage form, administration instructions, storage conditions, a 120 mL volume indication, and Amneal logos. It also shows the product NDC 69238-1535 and a barcode.*

FDA Label Image

Figure 1 (Clobazam Oral Suspension 2)

A bar graph depicting the percentage reduction in weekly drop seizure rate for placebo and three increasing dose groups: low, medium, and high. The graph shows progressively greater reductions in seizure rates from placebo through high dose, with corresponding sample sizes noted for each group and statistical significance indicated by asterisks below the bars.*

FDA Label Image

Figure 2 (Clobazam Oral Suspension 3)

A bar graph showing the proportion of patients (%) by reduction in weekly drop seizure frequency from baseline (%) for placebo and three Clobazam dose groups (Low, Medium, High). Categories of seizure reduction range from 'Worse' to '80 to 100' percent, with Clobazam High showing the highest patient proportion in the 80 to 100% reduction category.*

FDA Label Image

Figure A (Clobazam Oral Suspension 4)

Clobazam 2.5 mg/mL oral suspension bottle and outer carton by Amneal Pharmaceuticals NY LLC. The amber bottle includes a white cap and a bottle adapter, and comes with two transparent oral syringes for dosing. The carton indicates a 120 mL volume with usage instructions for oral administration only.*

FDA Label Image

Figure B (Clobazam Oral Suspension 5)

Clobazam oral suspension 2.5 mg/mL in a brown 120 mL bottle with a white child-resistant cap. The label includes the instruction to shake well before use. The product is labeled by Amneal Pharmaceuticals NY LLC for oral administration only.*

FDA Label Image

Figure C (Clobazam Oral Suspension 6)

An instructional diagram showing a person holding a child-resistant closure above an amber glass bottle, indicating how to align and screw the cap onto the bottle. The image visually guides the proper closure method for securing the container.*

FDA Label Image

Figure D (Clobazam Oral Suspension 7)

An instructional diagram of an oral dosing syringe showing labeled parts including the tip, dosage indicators, barrel, edge of plunger, and plunger. The syringe is marked with measurement increments and the text 'For Oral Administration Only.'*

FDA Label Image

Figure E (Clobazam Oral Suspension 8)

A close-up photo showing an oral dosing syringe inserted into the opening of an amber glass bottle. The syringe is marked with measurements in milliliters up to 10 mL and labeled "For Oral Administration Only." A finger is holding the syringe plunger, illustrating the measurement or dispensing process of liquid medication.*

FDA Label Image

Figure F (Clobazam Oral Suspension 9)

An instructional image showing the proper method for measuring Clobazam oral suspension 2.5 mg/mL using a 10 mL oral syringe attached to the brown medicine bottle. A hand is demonstrating pulling the syringe plunger downward to draw the liquid, with a black arrow indicating the downward motion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.